Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
GCCAGGTTTTATCCAAAGGTTACCAAATATTTACCATTGGATAAGGGTATTAAACCTTATTATCCAGAACATCTAGTTAATCATTACTTCCAAACTAGAC| |ACTATTTACACACTCTATGGAAGGCGGGTATATTATATAAGAGAGAAACAACACATAGCGCCTCATTTTGTGGGTCACCATATTCTTGGGAACAAGATCT
End
50662816/51366982 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/12809421; hsa-mir-103a-1/Downstream/2584522;
Upstream sequence
gctcacgctgggagctgtagactggagctgttcctattcggccatcttggctcctcccccCGACAATACCTTTTTAAAAAATGGATTTGGCAGATGGATC
Downstream sequence
CTCTAAATGATATGGGGCTGCCTCAACCCACCAGAGACATTACCTGAGAGTAATAAATGCACTTCAACAGCCTGATAGGTATTGGGAACAAGCCTTAAAT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.